Here are 20 key notes from orthopedic and spine device companies in the past week.
Medacta International named Daniel Abromowitz as general manager of its U.S. spine division.
Stryker finalized its acquisition of Invuity.
Intuitive Surgical released its third quarter 2018 financial results.
Stryker filed to extend its anti-trust deadline on the $1.4 billion K2M acquisition.
OrthoPediatrics received FDA 510(k) clearance for its new Response 4.5/5.0mm small stature scoliosis system.
Simplify Medical appointed Cindy Lynch as vice president of general counsel.
NuVasive named J. Christopher Barry as its new CEO, effective Nov. 5.
New York City-based Hospital for Special Surgery orthopedic surgeon David Mayman, MD, performed the first cases using OrthAlign's KneeAlign CFS system.
Viseon received FDA 510(k) clearance for its Voyant System for minimally invasive spine surgery.
UZ Brussel University Hospital in Belgium implemented Implanet's spine posterior fixation platform, Jazz. Belgium is the first country to perform spine surgery with the system.
The Orthopaedic Implant Company launched its OIC Semi-Extended Instrumentation at the Orthopaedic Trauma Association 2018 Annual Meeting in Orlando, Oct. 17-20.
MRI Interventions entered into an agreement with Clinical Laserthermia Systems to develop global navigation and laser ablation platforms for spine and neurosurgery.
Orthopedic device company Additive Orthopaedics received funding through New Jersey Economic Development Authority's N.J. CoVest Fund.
Medacta International launched a patient-matched posterior lumbar fusion solution at the North American Spine Society 2018 Annual Meeting in Los Angeles, Sept. 26-29.
Synoste raised $5.8 million to launch its smart skeletal deformation correction technology for orthopedic and spine applications.
SpineEx earned FDA 510(k) clearance for its Sagittae lateral lumbar interbody fusion device.
Ortho Development Corp. signed an exclusive agreement with DePuy Synthes, part of Johnson & Johnson Medical Device Companies, to promote its KASM Knee Articulating Spacer Mold in the U.S.
BoneSupport launched its own U.S. distributor network.
Kuros Biosciences' Dutch subsidiary Kuros Biosciences BV received a U.S. patent.
Kuros Biosciences submitted an FDA 510(k) clearance regulatory package for its Fibrin-PTH (KUR-113).